000640.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Stats
Current Price	KRW89 400
Today's Volume	4 632.00
Average Volume	7 385.00
Market Cap	558.81B
EPS	KRW0
P/E	0
ATR14	KRW163.95 (0.18%)

Volume Correlation

Long: -0.05 (neutral)

Short: -0.87 (strong negative)

Signal:(33.031) Neutral

Dong-A Socio Holdings Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dong-A Socio Holdings Correlation - Currency/Commodity

0.40
( neutral )

0.45
( neutral )

0.39
( neutral )

0.26
( neutral )

-0.04
( neutral )

-0.33
( neutral )

Dong-A Socio Holdings Financials

Annual 2022
Revenue: KRW1 014.86B
Gross Profit: KRW294.39B (29.01%)
EPS: KRW1 253.49

Q4 2022
Revenue: KRW261.12B
Gross Profit: KRW67.71B (25.93%)
EPS: KRW0

Q3 2022
Revenue: KRW269.44B
Gross Profit: KRW83.37B (30.94%)
EPS: KRW4 083.92

Q2 2022
Revenue: KRW261.04B
Gross Profit: KRW82.02B (31.42%)
EPS: KRW1 480.00

Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform. The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics services; and packaging and parcel delivery services. In addition, it offers mineral water under the Gayasan Cheonnyeonsu brand; POCARI SWEAT; Narangd cider; Oronamin C; Oran-C bio-PET; and STP2104, an mRNA based COVID-19 vaccine, which is in phase I clinical trial. Further, the company engages in the construction of industrial facilities, such as bio, pharmaceutical, food, logistics warehouses, education/research facilities, work/sales facilities, and public facilities; provides design, maintenance, and asset development services. Additionally, it provides IT systems development and maintenance. The company was founded in 1932 and is headquartered in Seoul, South Korea.